Address

New Science Ventures
645 Madison Avenue
20th Floor
New York, NY 10022
United States

Open map


Recent investment activity

Tags
KANDO id: 39519

Corporate information

Official name
New Science Ventures, LLC
Also known as
NSV
Registration country

Company type

Venture capital firm investing in both early and late stage companies using novel scientific approaches to address significant unmet needs.

Overview

New Science Ventures, LLC (NSV) is a venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value. NSV invests in companies using science-based innovations to address market needs in the life sciences and information technology sectors.



Funds managed

Fund Type Vintage Currency Committed capital
New Science Ventures Fund III (Offshore) LP Venture
New Science Ventures Fund III LP Venture

Funding rounds

Top investment portfolio themes
encryption (1)  
healthcare (1)  
genomics (1)  

Actual initial investment stage

Investment activity status
Active investor

Selected investments

Displaying 1 - 20 of 20
Profile Country Date Funding
BioProcessors Corp N/A
Celleration Inc Medical device company focused on developing and commercializing therapeutic ultrasound products Series C
Juventas Therapeutics Inc Series B
Light Sciences Oncology Inc Drug-device cancer therapy Series A
Trellis Bioscience N/A
Xoft Inc Developer of electronic brachytherapy (eBx) systems for radiation oncology applications. Series D
Achronix Semiconductor Corp Series C
Achronix Semiconductor Corp Series B
Achronix Semiconductor Corp Series A
Biovex Inc (Biovex Group Inc) Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. Series E
Biovex Inc (Biovex Group Inc) Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. Series F
BrightVolt Inc Design, development and scale manufacturing of ultra-thin film batteries. Series B led the round USD 5,000,000 (USD 5,000,000)
Celleration Inc Medical device company focused on developing and commercializing therapeutic ultrasound products Series E
Celleration Inc Medical device company focused on developing and commercializing therapeutic ultrasound products Series D
Paradigm Diagnostics Inc Series B USD 3,000,000 (USD 3,000,000)
Seahorse Bioscience Inc A developer of test and measurement equipment that is primarily used for cell assay tests in research laboratories. Venture
Seahorse Bioscience Inc A developer of test and measurement equipment that is primarily used for cell assay tests in research laboratories. Series D
TherOx Inc Series E
Vaultive Inc Developer of cloud-based data encryption. Series A Initial investment led the round
VUV Analytics Inc Developer of vacuum ultraviolet absorption spectroscopy. Series B led the round

Past employees

Selected Products / Customers

Financials